RG
EIDX
Redmile Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-452,295
| Closed | -$59.5M | – | 104 |
|
|
2020
Q4 | $59.5M | Sell |
452,295
-13,910
| -3% | -$1.83M | 0.72% | 42 |
|
|
2020
Q3 | $23.6M | Sell |
466,205
-127,637
| -21% | -$6.45M | 0.43% | 54 |
|
|
2020
Q2 | $28.3M | Sell |
593,842
-95,636
| -14% | -$4.56M | 0.52% | 49 |
|
|
2020
Q1 | $33.8M | Sell |
689,478
-11,700
| -2% | -$573K | 0.95% | 34 |
|
|
2019
Q4 | $40.2M | Sell |
701,178
-221,825
| -24% | -$12.7M | 0.96% | 30 |
|
|
2019
Q3 | $33.2M | Buy |
923,003
+44,600
| +5% | +$1.6M | 1.11% | 28 |
|
|
2019
Q2 | $27.3M | Buy |
878,403
+26,503
| +3% | +$824K | 0.77% | 39 |
|
|
2019
Q1 | $20M | Sell |
851,900
-1,600
| -0.2% | -$37.5K | 0.58% | 45 |
|
|
2018
Q4 | $11.7M | Sell |
853,500
-14,200
| -2% | -$195K | 0.47% | 48 |
|
|
2018
Q3 | $8.66M | Buy |
867,700
+676,700
| +354% | +$6.75M | 0.27% | 60 |
|
|
2018
Q2 | $3.89M | Buy |
+191,000
| New | +$3.89M | 0.13% | 63 |
|